Earn-Outs vs. Upfront Cash: What’s Right for Your Exit?
- Dr Allen Nazeri DDS MBA
- 6 days ago
- 6 min read
In every M&A transaction, one of the most sensitive—and strategic—discussion points is how the seller gets paid. While most business owners dream of a full cash payout at closing, reality often looks different. Buyers, especially in today’s cautious and data-driven market, increasingly prefer earn-outs to bridge valuation gaps, align incentives, and reduce post-closing risk.
But what exactly are earn-outs? And more importantly, how do you decide whether they’re right for your exit?
Let’s unpack how earn outs in M&A can either become a powerful value-creation tool—or a painful regret if structured poorly.
What Are Earn-Outs in M&A?
An earn-out is a deferred payment mechanism in which a portion of the purchase price is contingent upon the company achieving specific financial or operational milestones after closing. These milestones can include revenue targets, EBITDA thresholds, client retention rates, or even regulatory approvals.
In essence, the buyer says: “We’ll pay you more once your company performs as promised.”
For example, if a buyer agrees to acquire a healthcare services group for $10 million, they might offer $7 million upfront and an additional $3 million over two years—provided the business achieves an agreed-upon EBITDA or revenue performance.
Why Buyers Love Earn-Outs
From a buyer’s perspective, earn outs in M&A are risk-management tools. They reduce the possibility of overpaying for a company that fails to sustain its pre-sale momentum.
Buyers also use earn-outs to:
Preserve Cash Flow: Reducing upfront cash helps them fund more acquisitions or retain working capital for growth.
Align Interests: When a seller stays involved post-sale, an earn-out ensures they remain motivated to drive results.
Bridge Valuation Gaps: If a seller’s projections seem optimistic, an earn-out allows the buyer to say, “If it happens, we’ll pay for it.”
In short, earn-outs allow buyers to hedge risk while maintaining goodwill in negotiations.
Why Sellers Should Approach Earn-Outs Carefully
For sellers, earn-outs can look attractive on paper, particularly when they inflate the headline purchase price. But the truth is, not all earn-outs get paid.
Common challenges include:
Loss of Control: Once you sell, you rarely control how the company is managed post-closing. Operational decisions made by the new owner can directly affect your earn-out performance.
Accounting Manipulation: A buyer might allocate more expenses to your division, or change revenue recognition policies, making it difficult to achieve EBITDA targets.
Ambiguous Terms: Vague definitions of “net profit,” “gross revenue,” or “adjusted EBITDA” can lead to disputes—or worse, litigation.
If structured incorrectly, an earn-out can turn a promising deal into a stressful, post-closing tug-of-war.
Structuring an Earn-Out That Works
An earn-out doesn’t have to be risky. When properly drafted and negotiated, it can deliver the best of both worlds—upside for the seller and protection for the buyer. Here are five practical guidelines:
1. Define Clear, Auditable Metrics
Tie the earn-out to objective and verifiable measures such as GAAP-based EBITDA or revenue recognized under standard accounting rules. Avoid vague or discretionary performance indicators.
2. Limit the Duration
Earn-outs typically range from 12 to 36 months. The longer the term, the more uncertainty. Shorter earn-outs keep everyone focused and reduce the risk of post-closing friction.
3. Control What You Can
If your earn-out depends on operational performance, negotiate to retain a management or advisory role for the earn-out period. This ensures you can influence the outcome rather than relying entirely on the buyer’s execution.
4. Include “Change of Control” Protection
If the buyer sells the company before your earn-out is paid, you could be left empty-handed. Insist on a clause that accelerates or preserves your earn-out in the event of resale or material business changes.
5. Add Audit and Reporting Rights
Require quarterly financial statements and access to the company’s accounting records during the earn-out period. Transparency prevents misunderstandings and keeps both parties aligned.
Alternatives to Traditional Earn-Outs
Not every deferred payment must be performance-based. Some dealmakers use creative structures to balance risk and reward, such as:
Seller Notes: Fixed, interest-bearing payments over time regardless of performance.
Holdbacks or Escrows: A portion of the purchase price held for a specific period to cover indemnities or contingencies.
Milestone-Based Payments: Particularly common in biotech or medtech, where value realization depends on future regulatory approvals or product launches.
These alternatives can sometimes achieve the same purpose as earn-outs—bridging valuation gaps—without the post-closing tension.
Earn-Outs in Healthcare M&A
In healthcare transactions—especially for physician groups, diagnostic companies, and outpatient centers—earn outs in M&A are increasingly common. Buyers often use them when:
The seller’s revenue is highly dependent on key physicians or referral sources.
The company is expanding into new regions with uncertain payer mixes.
The deal involves technology integration or new service lines (e.g., wound care, oncology MSOs, behavioral health platforms).
For example, a wound care group projecting 30% growth post-acquisition might receive 70% of its valuation upfront and the remaining 30% tied to achieving specific patient volume and payer reimbursement goals.
These structures can unlock tremendous value—but only if both parties approach them with clarity, fairness, and realistic expectations.
Negotiation Tip: Focus on the Total Value, Not Just the Earn-Out
A common mistake sellers make is anchoring emotionally to the total “headline price.” The real question isn’t how much the buyer offers—it’s how much you collect.
A $12 million deal with $8 million guaranteed is often safer than a $15 million offer with $7 million contingent on future performance you can’t control.
When evaluating offers, ask:
What portion of the price is fixed versus contingent?
How likely is it that the earn-out metrics will be achieved?
Who decides what “performance” means?
What protections exist if the buyer changes course?
Your M&A advisor’s job is to model different scenarios, showing the range of possible outcomes—best, worst, and most probable—so you can make an informed decision.
When Earn-Outs Work Best
Earn-outs can be a win-win in deals where:
The seller remains actively involved post-closing.
Growth projections are credible but not yet proven.
Both parties trust each other and communicate transparently.
They tend to work poorly when:
The buyer takes over operations entirely and changes strategy.
Metrics are vague or hard to measure.
The relationship becomes adversarial after closing.
In other words, earn outs in M&A succeed when alignment continues after the ink dries.
Final Thoughts
The decision between earn-outs vs. upfront cash ultimately depends on your appetite for risk, your confidence in your company’s future performance, and your relationship with the buyer.
If structured correctly, an earn-out can bridge valuation gaps, protect both parties, and even maximize your total payout. But if poorly negotiated, it can become a source of frustration and financial loss.
As a seller, surround yourself with an experienced M&A advisor who understands both the art and science of deal structuring. Your advisor’s role is to translate market realities into a structure that safeguards your legacy while rewarding your years of work.
Because in M&A, how you get paid can matter just as much as how much you get paid.
Dr. Allen Nazeri, aka "Dr. Allen," boasts over 35 years of global experience as a healthcare entrepreneur. He is the Managing Director at American Healthcare Capital and Managing Partner at PRIME exits. Dr. Allen provides strategic growth consulting to leadership teams of both privately held and publicly listed companies, ensuring their preparedness for successful exits.
As an M&A advisor with over a decade of hands-on experience in deal-making, I’ve seen a lot. Deals stall. Offers get withdrawn. Valuations shift. But one of the most common, and underestimated reasons a sale can fall apart is partnership misalignment on the sell-side. Whether it's co-founders, silent partners, or family members with equity stakes, when there's a disconnect in vision, values, or urgency, deals can unravel quickly.
He holds a Dental Degree from Creighton University and an MBA in M&A and Investment Banking from the University of Bedfordshire. Dr. Allen is the author of "Value Engineering: Strategies to 10X the Value of Your Clinic and Dominate the Market!" and the brand new book "Selling Your Healthcare Company at a Premium". Dr. Allen offers a free valuation to business owners ready for a partial or complete exit strategy. Dr. Allen collaborates with strategic buyers, private equity firms, and institutional investors, taking direct accountability for the annual successful sell-side representation of nearly $750M in enterprise value.
To have a confidential discussion about your company and receive a free valuation, please email Allen@ahcteam.com or Allen@ahcpexits.com
You can now communicate with Dr. Allen's clone https://www.delphi.ai/drallen
Comments